Cape Investment Advisory »

Abcellera Biologics shares owned by Cape Investment Advisory

Quarter-by-quarter ownership of Abcellera Biologics (ABCL) shares owned by Cape Investment Advisory from 13F filings

Historical chart of Cape Investment Advisory investment in Abcellera Biologics

Tip: Access up to 7 years of quarterly data

All positions including Abcellera Biologics held by Cape Investment Advisory consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Abcellera Biologics by Cape Investment Advisory

Quarter filed Position value Share count Share price at filing
2026-06-30 $3.9k 500 7.85

More positions owned by Cape Investment Advisory

Schwab Strategic Tr Us Brd Mkt Etf (SCHB)
Schwab Strategic Tr Us Lcap Va Etf (SCHV)
Blackrock Etf Trust Ii Isha Flex In Etf (BINC)
Schwab Strategic Tr Us Lcap Gr Etf (SCHG)
Schwab Strategic Tr 1 5yr Corp Bd (SCHJ)
Schwab Strategic Tr Us Mid-cap Etf (SCHM)
Microsoft Corporation (MSFT)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr Core S&p500 Etf (IVV)
Schwab Strategic Tr Us Dividend Eq (SCHD)
Amazon (AMZN)
Apple (AAPL)
Schwab Strategic Tr Emrg Mkteq Etf (SCHE)

View all positions for Cape Investment Advisory

Top funds holding Abcellera Biologics

Baker Bros. Advisors
Capital World Investors
Two Sigma Investments
TD Waterhouse Canada
Bank of America Corporation
Ubs Global Asset Management Americas
Arrowpoint Asset Management
BlackRock
Susquehanna International
Driehaus Capital Management
Citadel Advisors
Morgan Stanley
UBS Group
Tudor Investment Corporation
Marshall Wace

View all funds holding Abcellera Biologics